Der nächste Konsensus zum Reizdarmsyndrom muss interdisziplinär sein

Zusammenfassung

Die vor einem Jahr veröffentlichte dritte Fassung des Rom-Konsensus zu den funktionellen Magen-Darm-Störungen wirft die Frage auf, ob eine Revision des Celle-Konsensus zum Reizdarmsyndrom von 1999 notwendig ist und wer diesen Konsensus tragen soll. Dazu wird in einem historischen Review die Geschichte der Rom-Kriterien und ihres Vorläufers (Manning-Kriterien) rekonstruiert und mit der parallelen Entwicklung der DSM/ICD-Klassifikationen der Allgemeinmedizin und der Psychiatrie/Psychosomatik kontrastiert. Es wird vorgeschlagen, statt eines weiteren Konsensus der Gastroenterologen zum Reizdarmsyndrom, der die Tendenz zur Isolation zwischen den Disziplinen fördert, einen - nationalen wie internationalen - gemeinsamen Konsens zwischen den beteiligten Fachgesellschaften (Allgemeinmedizin, Gastroenterologie/Neurogastroenterologie, Psychosomatik/Psychiatrie) zu formulieren.

Abstract

The publication of the Rome III consensus on functional bowel disorders one year ago has raised the question of whether a revision of the 1999 Celle consensus on the irritable bowel syndrome is necessary and who should be involved in this consensus. Therefore, the this review article attempts to reconstruct the history of the Rome criteria (and its predecessor, the Manning criteria) and contrasts this with the parallel history of the DSM/ICD classification in primary care and psychiatry/psychosomatics. The formulation of a common consensus between all medical societies (primary care, gastroenterology/neurogastroenterology, psychiatry/psychosomatics) is proposed instead of another consensus of gastroenterologists alone, in order to avoid the tendency - at both national and international levels - towards isolation between the medical subspecialties.

Reizdarmsyndrom - Celle-Konsensus - Rom-Kriterien - Geschichte

irritable bowel syndrome - consensus - Rome criteria - history

Literatur

• 1 Longstreth G F, Thompson W G, Chey W D. et al . Functional bowel disorders.  Gastroenterology. 2006;  130 1480-1491
• 2 Thompson W G, Creed F H, Drossman D A. et al . Functional bowel disease and functional abdominal pain.  Gastrenterol Int. 1992;  5 75-91
• 3 Thompson W G, Heaton K W, Irvine E J. et al . Functional bowel disorders and functional abdominal pain.  Gut. 1999;  45 (Suppl 2) 43-47
• 4 Hotz J, Enck P, Goebell H. et al . Reizdarmsyndrom. Definition, Diagnosesicherung, Pathophysiologie und Therapiemöglichkeiten. Konsensustagung der DGVS.  Z Gastroenterol. 1999;  37 685-700
• 5 Thompson W G, Dotevall G, Drossman D A. et al . Irritable bowel syndrome: guidelines for the diagnosis.  Gastroenteroly Int. 1989;  2 92-95
• 6 WONCA .ICHPPC-2-Defined. Oxford; Oxford University Press 1983 3rd editition
• 7 Manning A P, Thompson W G, Heaton K W. et al . Towards positive diagnosis of the irritable bowel syndrome.  Brit Med J. 1978;  2 653-654
• 8 Kruis W, Weinzierl M, Schussler P. et al . Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome.  Digestion. 1986;  34 196-201
• 9 Kruis W, Thieme C, Weinzierl M. et al . A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease.  Am J Gastroenterol. 1984;  87 1-7
• 10 Klein K B. Controlled treatment trials in the irritable bowel syndrome: a critique.  Gastroenterology. 1988;  95 232-241
• 11 Hotz J, Plein K. Effectiveness of plantago seed husks in comparison with wheat brain on stool frequency and manifestations of irritable colon syndrome with constipation.  Med Klin. 1994;  15 645-651
• 12 Madisch A, Holtmann G, Plein K. et al . Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial.  Aliment Pharmacol Ther. 2004;  19 271-279
• 13 Ziegenhagen D J, Kruis W. Cisapride treatment of constipation-predominant irritable bowel syndrome is not superior to placebo.  J Gastroenterol Hepatol. 2004;  19 744-749
• 14 Arnim U von, Peitz U, Vinson B. et al . STW 5, a phytopharmacon for patients with functional dyspepsia. Results of a multicenter, placebo-controlled double-blind study.  Am J Gastroenterol. 2007;  102 1268-1275
• 15 American Psychiatric Association .Diagnostic and statistical manual of mental disorders (DSM III). Washington D. C.; APA 1980 3rd edition
• 16 American Psychiatric Association .Diagnostic and statistical manual of mental disorders (DSM III-R). Washington, D.C; APA 1987 3rd edition
• 17 American Psychiatric Association .Diagnostic and statistical manual of mental disorders (DSM-IV-PC). Washington, D.C; APA 1994 4th edition: Primary Care Version
• 18 World Health Organisation .The ICD-10 classification of mental and behavioral disorders. Geneva; WHO 1992
• 19 Van der Horst H E, Dülmen A M, Schellevis F G. et al . Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome?.  Gut. 1997;  41 969-974
• 20 WONCA .ICPC-2, International Classification of Primary Care. Oxford; Oxford University Press 1998 2nd edition
• 21 Longstreth G F, Wolde-Tsadik van G. Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates.  Dig Dis Sci. 1993;  38 1581-1589
• 22 Drossman D A, Funch-Jensen P, Janssens J. et al . Identification of sub-groups of functional gastrointestinal disorders.  Gastroenterol Int. 1990;  3 159-172
• 23 Saito Y A, Talley N J, Melton II L J. et al . The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates.  Neurogastroenterol. 2003;  15 687-694
• 24 Thompson W G. The road to Rome.  Gastroenterology. 2006;  130 1552-1556
• 25 Mayou R A. Medically unexplained physical symptoms.  British Medical Journal. 1991;  303 534-535
• 26 Stone J, Wojcik W, Durrance D. et al . What should we say to patients with symptoms unexplained by disease? The „number needed to offend”.  British Medical Journal. 2003;  325 1449-1450
• 27 Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric disgnosis.  Am J Psychiat. 2003;  160 4-12
• 28 Sharpe M, Mayou R. Somatoform disorders: a help or hindrance to good patient care?.  British Journal of Psychiatry. 2004;  184 465-467
• 29 Mayou R, Kirmayer L J, Simon G. et al . Somatoform disorders: time for a new approach in DSM-V”.  American Journal of Psychiatry. 2005;  162 847-855
• 30 Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes:.  The Lancet. 2007;  369 946-955
• 31 Kroenke K. Physical symptom disorder: a simpler diagnostic category for somatization-spectrum conditions.  J Psychosom Res. 2006;  60 335-339
• 32 Klauser A G, Voderholzer W A, Schindelbeck N E. et al . Functional diagnostic work-up in patients with irritable bowel syndrome.  Z Gastroenterol. 1996;  34 273-278
• 33 Enck P, Whitehead W E, Schuster M M. Psychosomatik des Reizdarms: Spezifität klinischer Symptome, psychopathologischer Merkmale und motorischer Aktivität im Rektosigmoid.  Dtsch Med Wschr. 1988;  113 459-462
• 34 Jeonq H, Lee H R, Yoo B C. et al . Manning criteria in irritable bowel syndrome: its diagnostic significance.  Korean J Intern Med. 1993;  8 34-39
• 35 Talley N J, Phillips S F, Melton II L J. et al . Diagnostic value of the Manning criteria in irritable bowel syndrome.  Gut. 1990;  31 77-81
• 36 Smith R C, Greenbaum D S, Vancouver J B. et al . Gender differences in Manning criteria in the irritable bowel syndrome.  Gastreoenterology. 1991;  100 591-595
• 37 Icks A, Hastert B, Enck P. et al . Prevalence of functional bowel disorders and related health care seeking: a population-based study.  Z Gastroenterol. 2002;  40 177-183
• 38 Smith G D, Steinke D T, Kinnear M. et al . A comparison of irritable bowel syndrome patients managed in primary and secondary care: the episode IBS study.  Brit J Clin Pract. 2004;  54 503-507
• 39 Bijkerk C J, Wit N J, Stalman W A. et al . Irritable bowel syndrome in primary care: the patients’ and doctors’ view on symptoms, etiology and management.  Can J Gastroenterol. 2003;  17 363-368
• 40 Yawn B P, Lydick de E, Locke G R. et al . Do published guidelines for evaluation of irritable bowel syndrome reflect practice?.  BMC Gastroenterology. 2001;  I 11